Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 04:32:18 +0200Tue, 09 Jul 2024 15:56:00 +0200Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Date of authorisation: 24/09/2020, Revision: 11, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/jyselecaHuman medicines European public assessment report (EPAR): Jyseleca, filgotinib, Date of authorisation: 24/09/2020, Revision: 11, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/jyselecaTue, 09 Jul 2024 15:56:00 +0200Human medicineJyseleca : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5113_en_1.pdfJyseleca : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5113_en_1.pdfTue, 09 Jul 2024 15:54:00 +0200Human medicine